Related Experiment Video
Updated: Dec 28, 2025

Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
Diffusion-weighted imaging and apparent diffusion coefficient values for evaluating terminal ileitis in patients with
Evandra Durayski1, Guilherme Watte1,2, Gabriel Sartori Pacini2
1School of Medicine, Graduate Program in Medicine and Health Sciences, Pontifical Catholic University of Rio Grande do Sul (PUCRS), Porto Alegre, RS, Brazil.
Diffusion-weighted imaging (DWI) accurately detects terminal ileitis in Crohn's disease patients. Low apparent diffusion coefficient (ADC) values show high sensitivity for identifying active inflammation, aiding diagnosis.
Area of Science:
- Gastroenterology
- Radiology
- Medical Imaging
Background:
- Crohn's disease frequently affects the terminal ileum, causing inflammation (terminal ileitis).
- Accurate diagnosis of active inflammation is crucial for effective Crohn's disease management.
- Non-invasive imaging techniques are valuable for assessing disease activity.
Purpose of the Study:
- To evaluate the diagnostic accuracy of diffusion-weighted imaging (DWI) for terminal ileitis in Crohn's disease patients.
- To correlate DWI findings with established clinical and endoscopic measures of inflammation.
Main Methods:
- Retrospective analysis of 38 Crohn's disease patients undergoing MRI enterography with DWI.
- Patients categorized into active inflammation or inactive disease groups based on colonoscopy and biopsy.
- Measurement of apparent diffusion coefficient (ADC) values, MaRIA, and Clermont scores.
Main Results:
- DWI demonstrated high accuracy (89.4%) in detecting terminal ileitis.
- Active inflammation showed significantly restricted diffusion (lower ADC values), increased wall thickening, and higher MaRIA/Clermont scores.
- Optimal ADC cut-off of 2.1 × 10-3 mm2/s yielded 88.8% sensitivity and 95.0% specificity for inflammation.
Conclusions:
- Visual DWI analysis is accurate for detecting terminal ileitis in Crohn's disease.
- Low ADC values are sensitive indicators of colonoscopy-proven inflammation, supporting DWI's role in disease assessment.
More Related Videos
09:44Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
07:05Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
Published on: December 15, 2017
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Assessment of Diffusion and Perfusion
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF